Larsen & Toubro Infotech (LTI) has entered into a strategic partnership with eClinicalHealth to accelerate digital innovation in R&D Clinical Trials Management process for patient-centric drug development. The partnership will help clients decentralise clinical trials setting new benchmarks of excellence in the clinical research space, a statement from LTI said.
It also informed that the significance of the tie-up is based on the fact that 86 per cent of clinical studies are delayed due to challenges in patient engagement – mainly involving recruitment and retaining patients, which is a time-consuming and expensive process. The pandemic has further aggravated this challenge. It is in this context that eClinicalHealth, which is focussed on developing innovative clinical trial solutions, launched cloud-based patient-centric SaaS solution, Clinpal – which improves patient engagement for each clinical trial journey.
As part of this strategic partnership, LTI, with its digital, technical and lifesciences domain capabilities, will help accelerate the joint go-to-market pursuits and faster deployment for Clinpal Adopters. The solution will make use of exponential technologies such as analytics and AI to enhance patient engagement and faster clinical studies.
Speaking in this regard, Archana Ramanakumar, EVP and Global Delivery Head – Life Sciences, Media, Consumer and Technology, LTI, commented, “At LTI, we are on a journey to drive digital transformation for various aspects of clinical trials. Our endeavour with eClinicalHealth partnership is to accelerate and streamline the enablement of decentralised trials to reduce patient burden and drive acceleration of clinical trials. With this partnership, we aim to accelerate the development and deployment of eClinicalHealth’s ClinPal platform in clinical trials for the industry.”
Adding to it, Karl Landert, Chairman, Board, and CEO, eClinicalHealth, said, “The new normal world has put into limelight the benefits of a telemedicine ecosystem for larger benefit of end-users. Clinical trials assume an important function in development and improvement of treatment methods in order to enhance patients’ wellbeing, and De-Centralised Trials (DCT) have attained the highest order of patient preference. With our strategic partnership with LTI, our aim is to further scale and simplify patient engagement.”